Peripheral neuropathy decisions — 2025

The Board denied several claims for earlier effective dates and service connection, granted some claims for earlier effective dates, and remanded others for further development.

The Board denied the veteran's claims for service connection for peripheral neuropathy of both upper and lower extremities, finding no evidence that these conditions were incurred in or aggravated by service.

The Board denied increased ratings for the Veteran's peripheral neuropathy conditions, except for a 40% rating from September 18, 2023, for right and left lower extremity sciatic nerve peripheral neuropathy.

The Board denied service connection for a vision disability, to include hyperopia and presbyopia, and remanded several other claims including those for kidney, hypertension, sleep apnea, diabetes mellitus, lower extremity neuropathy, hip, knee, heart, neck, upper extremity radiculopathy, and TDIU.

The appeal was withdrawn by the Veteran, and the Board has no jurisdiction to review it.

The Veteran is granted special monthly compensation (SMC) based on the need for regular aid and attendance due to his service-connected disabilities.

The Board denied the veteran's appeal for an earlier effective date for service connection of chronic inflammatory demyelinating polyneuropathy in all extremities, as no new and material evidence was received within one year of the final denial in 2015.

The Board denied an earlier effective date for PTSD and major depressive disorder, denied service connection for colon polyps, type II diabetes, sinusitis, and chronic bronchitis, and granted service connection for allergic rhinitis, sleep apnea, and erectile dysfunction. Five neuropathy conditions were remanded for further development.

The Board granted service connection for multiple conditions, including ischemic heart disease with coronary artery disease, Type II diabetes mellitus, and Parkinson's disease, effective from October 20, 2017.

The Board granted service connection for Non Proliferative Diabetic Retinopathy with macular edema secondary to diabetes mellitus and denied the claims for a right shoulder condition, right upper extremity neuropathy, and skin cancer.

The Board granted service connection for several disabilities, including left thumb, left wrist, right hip, back, and sciatic nerve conditions, but denied service connection for diabetes mellitus.

The Board granted service connection for steatohepatitis and gastrointestinal impairment, to include chronic diarrhea and GERD. The claims for a chronic cough, right upper extremity neuropathy, left upper extremity neuropathy, facial scar, back disability, left hip disability, bilateral hand osteoarthritis, hemorrhoids, erectile dysfunction, and hypertension were denied.

The Board granted service connection for left and right lower extremity peripheral neuropathy, finding that the conditions are secondary to the Veteran's service-connected hypothyroidism.

The Board granted service connection for a cervical spine disability and right upper extremity radiculopathy, but remanded the claim for benign paroxysmal positional vertigo (BPPV) due to insufficient evidence.

The appeal for a higher rating for left lower extremity femoral neuropathy was denied, as the Veteran's condition did not meet the criteria for a rating in excess of 20 percent. The claim for an initial disability rating in excess of 10 percent for multinodular goiter with intermittent hyperthyroidism and syncopal episodes associated with paroxysmal atrial fibrillation is remanded.

The Board granted service connection for sleep apnea as secondary to the Veteran's service-connected hypertension and persistent depressive disorder with unspecified anxiety disorder and neurocognitive disorder, but remanded other claims related to diabetes, peripheral neuropathy, headaches, lumbar spine disability, radiculopathy, left ankle disorder, chronic fatigue, prostate cancer residuals, erectile dysfunction, and more.

The Board dismissed the appeals for service connection and increased ratings due to the Veteran's withdrawal of certain claims, and denied other claims based on a lack of evidence supporting current diagnoses or sufficient symptoms.

The Board denied an initial rating in excess of 70 percent for PTSD and remanded the claims for service connection for peripheral neuropathy, hypertension, obstructive sleep apnea, a lung condition, and entitlement to TDIU.

The Veteran withdrew his appeal for service connection for chronic inflammatory demyelinating polyneuropathy (CIDP), and the Board dismissed the appeal.

The Board denied service connection for hypertension and remanded the claims for benign prostatic hyperplasia, left lower extremity neuropathy, right lower extremity neuropathy, and obstructive sleep apnea.